Lotilibcin Dihydrochloride

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLotilibcin Dihydrochloride
Drug Alias Name罗替布星lotilibcinelotilibcina洛替利星lotilibcinum +[8] 
ClassificationSmall molecules > Synthetic peptideSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell membrane modulators
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesArigen Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArigen Pharmaceutical
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A